Skandinaviska Enskilda Banken (SEB)’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,499	Closed	-$506K	–	834
2024 Q1	$506K	Buy	+14,499	New	+$529K	﹤0.01%	708

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s INBX Position: Q2 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 14,499 shares — an estimated $506K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $506K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 14,499 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $506K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Skandinaviska Enskilda Banken (SEB)'s Inhibrx, Inc. Common Stock position peaked at $506K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2024, filed 13 Aug 2024.